Pediatric Thoracic Empyema—Outcomes of Intrapleural Thrombolytics: Ten Years of Experience

Introduction. Pediatric thoracic empyema is a special entity with increasing frequency. Consensus regarding the best management strategy is still evolving. We describe our single-center 10-year experience adopting intrapleural thrombolytics using tissue plasminogen activator as first-line treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Baram, Aram, Yaldo, Fitoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281637/
https://www.ncbi.nlm.nih.gov/pubmed/32551331
http://dx.doi.org/10.1177/2333794X20928200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281637/
https://www.ncbi.nlm.nih.gov/pubmed/32551331
http://dx.doi.org/10.1177/2333794X20928200

Ejemplares similares